Northern Trust’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $849K | Buy |
228,158
+3,206
| +1% | +$22.1K | ﹤0.01% | 3412 |
|
|
2025
Q4 | $1.84M | Sell |
224,952
-13,673
| -6% | -$101K | ﹤0.01% | 3048 |
|
|
2025
Q3 | $1.76M | Sell |
238,625
-4,770
| -2% | -$36.1K | ﹤0.01% | 3110 |
|
|
2025
Q2 | $1.98M | Buy |
243,395
+8,264
| +4% | +$55.7K | ﹤0.01% | 2997 |
|
|
2025
Q1 | $1.66M | Buy |
235,131
+13,633
| +6% | +$84.7K | ﹤0.01% | 3018 |
|
|
2024
Q4 | $1.65M | Buy |
221,498
+28,019
| +14% | +$179K | ﹤0.01% | 3133 |
|
|
2024
Q3 | $954K | Buy |
193,479
+121,630
| +169% | +$635K | ﹤0.01% | 3378 |
|
|
2024
Q2 | $369K | Buy |
71,849
+10,199
| +17% | +$60.4K | ﹤0.01% | 3616 |
|
|
2024
Q1 | $327K | Sell |
61,650
-18
| -0% | -$129 | ﹤0.01% | 3715 |
|
|
2023
Q4 | $382K | Sell |
61,668
-1,508
| -2% | -$10.5K | ﹤0.01% | 3637 |
|
|
2023
Q3 | $477K | Buy |
63,176
+5,981
| +10% | +$54.7K | ﹤0.01% | 3533 |
|
|
2023
Q2 | $553K | Sell |
57,195
-170,595
| -75% | -$1.04M | ﹤0.01% | 3521 |
|
|
2023
Q1 | $860K | Buy |
227,790
+218
| +0.1% | +$1.22K | ﹤0.01% | 3276 |
|
|
2022
Q4 | $1.47M | Sell |
227,572
-188
| -0.1% | -$1.55K | ﹤0.01% | 3135 |
|
|
2022
Q3 | $2.02M | Sell |
227,760
-4,026
| -2% | -$40.9K | ﹤0.01% | 3004 |
|
|
2022
Q2 | $2.31M | Sell |
231,786
-2,256
| -1% | -$22.3K | ﹤0.01% | 2976 |
|
|
2022
Q1 | $2.71M | Sell |
234,042
-10,327
| -4% | -$115K | ﹤0.01% | 2943 |
|
|
2021
Q4 | $2.71M | Sell |
244,369
-25,973
| -10% | -$252K | ﹤0.01% | 3066 |
|
|
2021
Q3 | $2.49M | Sell |
270,342
-1,631
| -0.6% | -$17.7K | ﹤0.01% | 3156 |
|
|
2021
Q2 | $3.06M | Sell |
271,973
-6,783
| -2% | -$78.2K | ﹤0.01% | 3140 |
|
|
2021
Q1 | $2.96M | Sell |
278,756
-25,161
| -8% | -$283K | ﹤0.01% | 3044 |
|
|
2020
Q4 | $3.3M | Sell |
303,917
-13,501
| -4% | -$139K | ﹤0.01% | 2923 |
|
|
2020
Q3 | $3.09M | Sell |
317,418
-22,818
| -7% | -$217K | ﹤0.01% | 2828 |
|
|
2020
Q2 | $2.71M | Sell |
340,236
-411
| -0.1% | -$4.24K | ﹤0.01% | 2865 |
|
|
2020
Q1 | $2.96M | Sell |
340,647
-4,451
| -1% | -$46.3K | ﹤0.01% | 2625 |
|
|
2019
Q4 | $3.9M | Buy |
345,098
+9,886
| +3% | +$105K | ﹤0.01% | 2733 |
|
|
2019
Q3 | $3.64M | Sell |
335,212
-3,293
| -1% | -$35.8K | ﹤0.01% | 2733 |
|
|
2019
Q2 | $3.17M | Buy |
338,505
+9,160
| +3% | +$92.5K | ﹤0.01% | 2806 |
|
|
2019
Q1 | $4.04M | Sell |
329,345
-11,209
| -3% | -$137K | ﹤0.01% | 2675 |
|
|
2018
Q4 | $4.03M | Sell |
340,554
-12,731
| -4% | -$175K | ﹤0.01% | 2637 |
|
|
2018
Q3 | $5.09M | Buy |
353,285
+4,527
| +1% | +$62.6K | ﹤0.01% | 2675 |
|
|
2018
Q2 | $5.2M | Sell |
348,758
-7,090
| -2% | -$98.5K | ﹤0.01% | 2663 |
|
|
2018
Q1 | $4.64M | Buy |
355,848
+1,380
| +0.4% | +$18.1K | ﹤0.01% | 2634 |
|
|
2017
Q4 | $4.47M | Sell |
354,468
-597
| -0.2% | -$7.54K | ﹤0.01% | 2679 |
|
|
2017
Q3 | $4.6M | Buy |
355,065
+2,195
| +0.6% | +$28.9K | ﹤0.01% | 2683 |
|
|
2017
Q2 | $5.24M | Buy |
352,870
+6,189
| +2% | +$86.2K | ﹤0.01% | 2612 |
|
|
2017
Q1 | $4.16M | Buy |
346,681
+3,165
| +0.9% | +$40.1K | ﹤0.01% | 2670 |
|
|
2016
Q4 | $4.74M | Sell |
343,516
-6,418
| -2% | -$88.9K | ﹤0.01% | 2576 |
|
|
2016
Q3 | $4.69M | Buy |
349,934
+3,816
| +1% | +$46.2K | ﹤0.01% | 2552 |
|
|
2016
Q2 | $3.72M | Buy |
346,118
+8,047
| +2% | +$88.8K | ﹤0.01% | 2658 |
|
|
2016
Q1 | $3.57M | Buy |
338,071
+2,047
| +0.6% | +$22.5K | ﹤0.01% | 2632 |
|
|
2015
Q4 | $3.98M | Buy |
336,024
+3,635
| +1% | +$44.6K | ﹤0.01% | 2601 |
|
|
2015
Q3 | $3.88M | Buy |
332,389
+4,729
| +1% | +$62.7K | ﹤0.01% | 2603 |
|
|
2015
Q2 | $4.73M | Sell |
327,660
-3,821
| -1% | -$55.1K | ﹤0.01% | 2556 |
|
|
2015
Q1 | $4.62M | Sell |
331,481
-288
| -0.1% | -$3.98K | ﹤0.01% | 2553 |
|
|
2014
Q4 | $4.58M | Sell |
331,769
-19,815
| -6% | -$256K | ﹤0.01% | 2566 |
|
|
2014
Q3 | $4.31M | Sell |
351,584
-22,694
| -6% | -$283K | ﹤0.01% | 2597 |
|
|
2014
Q2 | $4.67M | Sell |
374,278
-77,413
| -17% | -$911K | ﹤0.01% | 2560 |
|
|
2014
Q1 | $5.04M | Buy |
451,691
+20,848
| +5% | +$229K | ﹤0.01% | 2546 |
|
|
2013
Q4 | $5.22M | Buy |
430,843
+21,344
| +5% | +$255K | ﹤0.01% | 2535 |
|
|
2013
Q3 | $5M | Buy |
409,499
+27,673
| +7% | +$386K | ﹤0.01% | 2507 |
|
|
2013
Q2 | $5.04M | Buy |
+381,826
| New | +$5.28M | ﹤0.01% | 2411 |
|
Other funds holding LFCR
2L
WC
LPAM
GRIM
3C
VCM
GC
Northern Trust's LFCR Position: Q1 2026 in Review
Northern Trust increased its Lifecore Biomedical (LFCR) stake by 1.4% in Q1 2026, buying an estimated $22.1K and bringing the position to 228,158 shares worth $849K. The position accounts for ﹤0.01% of the portfolio, ranked #3412.
Northern Trust first reported a position in LFCR in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.24M in Q2 2017. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.
- Northern Trust held 228,158 shares of Lifecore Biomedical worth $849K as of Q1 2026.
- Northern Trust bought 3,206 Lifecore Biomedical shares in Q1 2026, an estimated $22.1K.
- Lifecore Biomedical made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3412 holding.
- Northern Trust first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Lifecore Biomedical position peaked at $5.24M in Q2 2017.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.